Pharmaceuticals
Price cap on 108 “non-essential” drugs lifted as govt reverses stance
23 Sep 2014
Drug firms are now expected to jack up prices of a range of drugs used in the treatment of diseases from diabetes and cardio-vascular diseases to HIV/AIDS
Canadian regulator asks Ipca to stop API exports
22 Sep 2014
Indian Pharma regulator cuts prices of 43 drug formulations
19 Sep 2014
The price cuts will make formulations used to treat infections and gastro intestinal disorders, a few vaccines, and commonly used antibiotics such as Ciprofloxacin HCl, Cloxacillin and Rifampicin, cheaper by up to 50 per cent
Ranbaxy grilled by US Justice Dept over Medicaid drug pricing
18 Sep 2014
The US Justice Department has requested Ranbaxy for documents and information through a civil investigative demand, though it does not allege any wrongdoing
US judge upholds Ranbaxy-Pfizer Lipitor marketing deal
13 Sep 2014
In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor
Strong US generic market lifts pharma growth
By By B G Shirsat | 11 Sep 2014
FTC sues AbbVie, Teva over AndroGel delay
09 Sep 2014
Sun-Ranbaxy merger: competition panel demands more details
28 Aug 2014
This is probably the first instance where the fair trade watchdog has ordered a public scrutiny of a proposed merger and acquisition deal to ensure compliance to fair trade regulation
Roche to buy InterMune for $8.3 bn
25 Aug 2014
The purchase of InterMune, a developer of a drug for pulmonary fibrosis, would add $1 billion in global sales for Roche by 2019
Ranbaxy faces fresh US penalty of Rs242 cr over Toansa-made API
22 Aug 2014
This is the second such penalty for the company, which paid $500 million to the US department of justice (DoJ) in May 201
Pfizer hit with lawsuits over Lipitor
11 Aug 2014
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
